Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × durvalumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 25 Lung Neoplasms 11 Colorectal Neoplasms 10 Ovarian Neoplasms 9 Breast Neoplasms 9 Urinary Bladder Neoplasms 7 Small Cell Lung Carcinoma 7 Prostatic Neoplasms 6 Neoplasms 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Recurrence 5 Carcinoma 5 Pancreatic Neoplasms 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Carcinoma, Hepatocellular 4 Recurrent Squamous Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Mouth Neoplasms 3 Mesothelioma 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urothelial Cancer 2 Thyroid Neoplasms 2 Solid Tumor 2 Sarcoma 2 Oropharyngeal Neoplasms 2

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡